Flagship Harbor Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,069
Closed -$189K 2230
2020
Q1
$189K Sell
1,069
-925
-46% -$174K 0.04% 401
2019
Q4
$381K Buy
1,994
+3
+0.2% +$541 0.07% 286
2019
Q3
$335K Sell
1,991
-546
-22% -$89K 0.07% 290
2019
Q2
$424K Buy
2,537
+804
+46% +$111K 0.09% 234
2019
Q1
$253K Hold
1,733
0.05% 345
2018
Q4
$231K Buy
1,733
+4
+0.2% +$656 0.06% 316
2018
Q3
$333K Buy
1,729
+950
+122% +$175K 0.06% 294
2018
Q2
$129K Buy
+779
New +$125K 0.03% 507
2017
Q4
Sell
-1,040
Closed -$209K 387
2017
Q3
$209K Sell
1,040
-53
-5% -$12.3K 0.07% 312
2017
Q2
$265K Sell
1,093
-40
-4% -$9.4K 0.09% 258
2017
Q1
$270K Sell
1,133
-201
-15% -$46.8K 0.1% 232
2016
Q4
$288K Buy
+1,334
New +$276K 0.12% 202

Other funds holding AGN

Flagship Harbor Advisors's AGN Position: Q2 2020 in Review

Flagship Harbor Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,069 shares — an estimated $189K sold.

Flagship Harbor Advisors first reported a position in AGN in Q4 2016 and held it in 12 quarters. The position peaked at $424K in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Flagship Harbor Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 1,069 Allergan plc shares in Q2 2020, an estimated $189K.
  • Flagship Harbor Advisors first reported a position in Allergan plc in Q4 2016 and held it in 12 quarters.
  • Flagship Harbor Advisors's Allergan plc position peaked at $424K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Flagship Harbor Advisors's 13F filing for Q2 2020, filed 31 Jul 2020.